Concepedia

Gene V. Wallenstein

GV

51

Publications

8.6K

Citations

35

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

Metroplex Clinical Research Center

Stanford University

Albany Medical Center Hospital

Seoul National University

Gene V. Wallenstein is an author at Pfizer (United States) specializing in neuroscience, social sciences, and medicine.

ORCID

Top concepts

Publications per year

1994–2022

51

Publications

51

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

Roy Fleischmann, Joel M. Kremer, John J. Cush et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen et al. · New England Journal of Medicine · 2012 · 922 citations · Full text

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

Eun Bong Lee, Roy Fleischmann, Stephen Hall et al. · New England Journal of Medicine · 2014 · 761 citations · Full text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman et al. · The Lancet · 2013 · 714 citations

, , +13

Gamma Frequency–Range Abnormalities to Auditory Stimulation in Schizophrenia

Jun Soo Kwon, Brian F. O’Donnell, Gene V. Wallenstein et al. · Archives of General Psychiatry · 1999 · 656 citations · Full text

Rows per page

1–5 of 51